Mohammad Fathalipour
Overview
Explore the profile of Mohammad Fathalipour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ameri A, Farashahinejad M, Davoodian P, Safa O, Hassaniazad M, Parsaii M, et al.
Medicine (Baltimore)
. 2024 Sep;
103(22):e38289.
PMID: 39259072
Background: Ginger, a potent antiviral, anti-inflammatory, and antioxidant remedy, is a potential therapeutic option for COVID-19. However, there was not enough clinical evidence about ginger and COVID-19. We evaluated the...
2.
Ameri A, Pourseyedi F, Davoodian P, Safa O, Hassanipour S, Fathalipour M
Medicine (Baltimore)
. 2024 Aug;
103(34):e39142.
PMID: 39183421
Background: Deferoxamine is a potent iron chelator that could remove iron from the virus, and severe acute respiratory syndrome coronavirus 2 requires iron to replication. Also, deferoxamine has antioxidant and...
3.
Fathi F, Ameri A, Safa O, Hassaniazad M, Fathalipour M
Medicine (Baltimore)
. 2024 Feb;
103(8):e35549.
PMID: 38394514
Coronavirus disease 2019 (COVID-19) vaccines are the most effective tools in managing the pandemic. However, the concern about these vaccines is the occurrence of unwanted adverse events (AEs). This study...
4.
Ameri A, Farashahinejad M, Davoodian P, Safa O, Kusha A, Dadvand H, et al.
Inflammopharmacology
. 2023 Oct;
31(6):3037-3045.
PMID: 37847472
Licorice extract (glycyrrhizin), a potent antiviral, anti-inflammatory, and antioxidant remedy, is a potential therapeutic option for COVID-19. We evaluated the efficacy and safety of licorice in patients with moderate COVID-19....
5.
Mansour-Ghanaei F, Masihipour B, Fathalipour M, Hassanipour S, Sokhanvar H, Mansour-Ghanaei A, et al.
Evid Based Complement Alternat Med
. 2022 Dec;
2022:9794901.
PMID: 36523418
The incidence of microbial resistance is growing, and new rescue regimens are needed to treat () infection. This study aimed to evaluate levofloxacin-based quadruple therapies' efficacy, safety, and tolerability in...
6.
Ameri A, Frouz Asadi M, Ziaei A, Vatankhah M, Safa O, Kamali M, et al.
Inflammopharmacology
. 2022 Nov;
31(1):265-274.
PMID: 36401728
Patients with COVID-19 have shown melatonin deficiency. We evaluated the efficacy and safety of administration oral melatonin in patients with COVID-19-induced pneumonia. Patients were randomly assigned in a 1:1 ratio...
7.
Hassaniazad M, Farshidi H, Gharibzadeh A, Bazram A, Khalili E, Noormandi A, et al.
J Med Virol
. 2022 Mar;
94(7):3184-3191.
PMID: 35292989
Favipiravir (FVP), lopinavir/ritonavir (LPV/RTV), and interferon-beta (INF-beta) are considered as potential treatments for COVID-19. We examined the efficacy and safety of FVP and INF-beta compared to LPV/RTV and INF-beta combinations...
8.
Doostkam A, Fathalipour M, Anbardar M, Purkhosrow A, Mirkhani H
Can J Gastroenterol Hepatol
. 2022 Feb;
2022:2868904.
PMID: 35186807
Background: At present, nonalcoholic fatty liver disease (NAFLD) does not have an approved pharmacologic therapy. The present study investigated the protective effects and possible mechanisms of milk thistle ( L.)...
9.
Hassanipour S, Arab-Zozani M, Amani B, Heidarzad F, Fathalipour M, Martinez-de-Hoyo R
Sci Rep
. 2022 Feb;
12(1):1996.
PMID: 35105913
No abstract available.
10.
Hassaniazad M, Eftekhar E, Rahnama Inchehsablagh B, Kamali H, Tousi A, Jaafari M, et al.
Phytother Res
. 2021 Sep;
35(11):6417-6427.
PMID: 34541720
In COVID-19 patients, cytokine storm due to excessive immune responses can cause severe complications. In this study, we investigated the effect of curcumin nanomicelles on clinical outcome and cellular immune...